278 related articles for article (PubMed ID: 1739930)
1. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in medulloblastoma, including DNA ploidy.
Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy.
Tomita T; Yasue M; Engelhard HH; McLone DG; Gonzalez-Crussi F; Bauer KD
Cancer; 1988 Feb; 61(4):744-9. PubMed ID: 3338037
[TBL] [Abstract][Full Text] [Related]
4. DNA content--a prognostic factor in childhood medulloblastoma?
Mandel M; Toren A; Nativ O; Rechavi G; Neumann Y; Nass D; Mor Y
Acta Oncol; 1993; 32(6):691-2. PubMed ID: 8260190
[No Abstract] [Full Text] [Related]
5. Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
Chou PM; Reyes-Mugica M; Barquin N; Yasuda T; Tan X; Tomita T
Pediatr Neurosurg; 1995; 23(6):283-91; discussion 291-2. PubMed ID: 8743996
[TBL] [Abstract][Full Text] [Related]
6. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
[TBL] [Abstract][Full Text] [Related]
7. Relation of tumor-cell ploidy to survival in children with medulloblastoma.
Gajjar AJ; Heideman RL; Douglass EC; Kun LE; Kovnar EH; Sanford RA; Fairclough DL; Ayers D; Look AT
J Clin Oncol; 1993 Nov; 11(11):2211-7. PubMed ID: 8229136
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic outcome of medulloblastoma in 49 children.
Jaing TH; Hung IJ; Yang CP; Wang HS; Hung PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):279-85. PubMed ID: 7572172
[TBL] [Abstract][Full Text] [Related]
9. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
10. Molecular progression of SHH-activated medulloblastomas.
Korshunov A; Okonechnikov K; Sahm F; Ryzhova M; Stichel D; Sievers P; Meyer J; Schrimpf D; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; von Deimling A; Kool M
Acta Neuropathol; 2019 Aug; 138(2):327-330. PubMed ID: 31030238
[No Abstract] [Full Text] [Related]
11. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.
Caputy AJ; McCullough DC; Manz HJ; Patterson K; Hammock MK
J Neurosurg; 1987 Jan; 66(1):80-7. PubMed ID: 3783262
[TBL] [Abstract][Full Text] [Related]
12. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
15. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system.
Jenkin D; Goddard K; Armstrong D; Becker L; Berry M; Chan H; Doherty M; Greenberg M; Hendrick B; Hoffman H
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):265-74. PubMed ID: 2394606
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma: evaluation of proliferative index by monoclonal antibody Mib-1, its prognostic correlation and therapeutic implications.
Ferrari AF; Araújo MB; Aguiar PH; Plese JP
Arq Neuropsiquiatr; 2003 Sep; 61(3A):547-51. PubMed ID: 14513155
[TBL] [Abstract][Full Text] [Related]
17. The radiation treatment of medulloblastoma.
Jenkin D
J Neurooncol; 1996 Jul; 29(1):45-54. PubMed ID: 8817415
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD
Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar medulloblastomas in adults.
Tekkök IH; Süzer T; Ozgen T; Erbengi A
Neurosurg Rev; 1991; 14(2):135-40. PubMed ID: 1870719
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas.
Lindsey JC; Hill RM; Megahed H; Lusher ME; Schwalbe EC; Cole M; Hogg TL; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
J Clin Oncol; 2011 Apr; 29(12):e344-6; author reply e347-8. PubMed ID: 21357788
[No Abstract] [Full Text] [Related]
[Next] [New Search]